Patent
   D974390
Priority
Jan 15 2021
Filed
Jan 15 2021
Issued
Jan 03 2023
Expiry
Jan 03 2038
Assg.orig
Entity
unknown
6
22
n/a
The ornamental design for a display screen or portion thereof with graphical user interface for selecting a report with an abstraction tool, as shown and described.

FIG. 1 is a front view of a first image in a sequence of a display screen or portion thereof with graphical user interface for selecting a report with an abstraction tool showing our new design;

FIG. 2 is a front view of a second image thereof;

FIG. 3 is a front view of a third image thereof; and,

FIG. 4 is a front view of a fourth image thereof.

The outermost broken lined rectangles indicate a boundary of a display screen or a portion thereof and form no part of the claimed design. The broken lined text and characters form no part of the claimed design.

The appearance of the animated images sequentially transition from FIG. 1 to FIG. 4. The process or period in which one image transitions to another forms no part of the claimed design.

Barnard, Cindy K., Byrapuneni, Sambasivarao, Chapagain, Diwakar, Dorge, Archana P., Jeu, Catherine M., Kesavan, Rengaraja, Parekh, Kaushal D., Ramanathan, Raman, Schlossman, David M., Sharma, Vishakha

Patent Priority Assignee Title
ER1559,
ER2829,
ER620,
ER7398,
ER7423,
ER792,
Patent Priority Assignee Title
20160349949,
20190391825,
D733176, Aug 14 2013 BETTER CHINESE, LLC.; BETTER CHINESE, LLC , Display screen or portion thereof with transitional image sequence
D809530, Dec 20 2016 SMARTORG, INC.; SMARTORG, INC Display screen or portion thereof with an animated graphical user interface
D836652, Oct 04 2016 Honeywell International Inc.; Honeywell International Inc Display screen or portion thereof with animated graphical user interface
D841031, Sep 21 2016 EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC Display screen with animated graphical user interface
D860238, Mar 28 2018 INNOPLEXUS AG Display screen with transitional graphical user interface
D868104, May 24 2018 ADP, INC Display screen or portion thereof with an animated graphical user interface
D871443, May 24 2018 ADP, INC Display screen or portion thereof with an animated graphical user interface
D874481, Jun 29 2018 INNOPLEXUS AG Display screen with transitional graphical user interface
D881211, Dec 22 2015 JPMORGAN CHASE BANK, N A Display screen or portion thereof with a graphical user interface
D888739, May 24 2018 ADP, INC Display screen or a portion thereof with a graphical user interface
D890199, Sep 28 2018 INNOPLEXUS AG Display screen with transitional graphical user interface
D892849, Sep 27 2018 INNOPLEXUS AG; INNOPLEXUS CONSULTING SERVICES PVT LTD Display screen with transitional graphical user interface
D902226, Sep 12 2016 Roche Molecular Systems, Inc Display screen or portion thereof with graphical user interface for timeline information for multidisciplinary cancer treatment planning
D905734, May 24 2018 ADP, INC Display screen or a portion thereof with an animated graphical user interface
D906360, Sep 18 2016 Display screen or portion thereof with an animated graphical user interface
D922420, Nov 15 2019 NETWOLVES NETWORK SERVICES, LLC Display screen with graphical user interface for network monitoring dashboard
D930022, Oct 14 2019 ASTEK POLSKA SP ZO O ; ROCHE POLSKA SP ZO O; Roche Molecular Systems, Inc; F HOFFMANN-LA ROCHE AG Display screen or portion thereof with graphical user interface for interactive guidelines for multidisciplinary cancer treatment planning
D931314, Oct 14 2019 ASTEK POLSKA SP ZO O ; ROCHE POLSKA SP ZO O; Roche Molecular Systems, Inc; F HOFFMANN-LA ROCHE AG Display screen or portion thereof with graphical user interface for interactive guidelines for multidisciplinary cancer treatment planning
D936078, Oct 29 2019 Optum, Inc. Display screen or portion thereof with animated graphical user interface
D940172, Oct 14 2019 ROCHE POLSKA SP ZO O; Roche Molecular Systems, Inc; F HOFFMANN-LA ROCHE AG; ASTEK POLSKA SP ZO O Display screen or portion thereof with graphical user interface for interactive guidelines for multidisciplinary cancer treatment planning
///////////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Jan 15 2021Roche Molecular Systems, Inc.(assignment on the face of the patent)
Mar 16 2021RAMANATHAN, RAMANRoche Molecular Systems, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0563840044 pdf
Mar 16 2021PAREKH, KAUSHAL D Roche Molecular Systems, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0563840044 pdf
Mar 16 2021SHARMA, VISHAKHARoche Molecular Systems, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0563840044 pdf
Mar 16 2021DORGE, ARCHANA P Roche Molecular Systems, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0563840044 pdf
Mar 16 2021CHAPAGAIN, DIWAKARRoche Molecular Systems, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0563840044 pdf
Mar 17 2021BYRAPUNENI, SAMBASIVARAORoche Molecular Systems, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0563840044 pdf
Mar 17 2021SCHLOSSMAN, DAVID M Roche Molecular Systems, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0563840044 pdf
Mar 22 2021BARBARD, CINDY K Roche Molecular Systems, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0563840044 pdf
Mar 26 2021JEU, CATHERINE M Roche Molecular Systems, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0563840044 pdf
May 10 2021KESAVAN, RENGARAJA PERUMALRoche Molecular Systems, IncASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0563840044 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule